Compare Novartis AG (NVS) vs ProShares UltraPro QQQ ETF (TQQQ) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Novartis AG vs ProShares UltraPro QQQ ETF — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while ProShares UltraPro QQQ ETF trades at $71.42. The key difference: Novartis AG pays a 3.17% dividend while ProShares UltraPro QQQ ETF pays none. Which is the better fit depends on your goals.
| NVS | TQQQ | |
|---|---|---|
Market Cap | $290.25B | — |
Sector | Health | Leveraged / Inverse |
52-Week High | $168.62 | $87.22 |
52-Week Low | $113.50 | $37.89 |
Enterprise Value | $330.27B | — |
Dividend Yield | 3.17% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Novartis AG
Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →About ProShares UltraPro QQQ ETF
TQQQ is a leveraged ETF that seeks daily investment results, before fees and expenses, that correspond to three times (3x) the daily performance of the Nasdaq-100 Index. It is one of the most liquid and actively traded instruments in the market, designed for sophisticated traders to amplify short-term bullish exposure to large-cap non-financial growth stocks, predominantly in the technology and communication sectors.
Read more on TQQQ →
